TORREJÓN DE ARDOZ, Spain -- With speed and determination, nurses, doctors and caretakers move in and out of glassed rooms with beds hooked up to tubes, cables and monitors. The cadence of beeps serves as a soundtrack to their workday, underpinned by a constant chatter of voices at half pitch and the snapping of rubber gloves as they're removed by staff ending their shifts.
It’s another day at the intensive care ward at the Torrejón de Ardoz University Hospital, on the outskirts of the European capital that has so far seen the worst of the second wave of the pandemic. Still, hospital staff count themselves lucky: Despite having had to add nine intensive care beds to the usual 16, the hospital hasn't had to postpone treatment for any other patients.
Many others in the region have.
At the peak of the first wave, ICU wards were given over to haste, desperation and even cluelessness about what to do. Now, a well-oiled machinery saves some lives and loses others to COVID-19, but without the doomsday atmosphere of March and April.
“It's no longer like being in a war zone field hospital,” said Velayos. “But the reality is that we are working way over our normal capacity. This is a situation that is absolutely exceptional and that we shouldn't have reached under any scenario.”
Treatment has improved, although the time that COVID-19 patients spend under intensive care can still stretch for weeks or even months, taking up desperately-needed hospital resources, said Dr. María José García Navarro, medical director of the Torrejón de Ardoz University Hospital, where 49 patients are now being treated, 35 in normal beds and 14 in ICUs.
“We have learned to quickly identify the symptoms and what treatment to apply, which are the drugs that are useful and which aren’t, even if that narrowed down our options,” García Navarro said. Corticosteroids that were experimented with at the onset of the pandemic have now discarded on behalf of Remdesivir, the drug that has yielded better results so far.
With more experience, García Navarro and her team have been able to fine-tune the timings of when to apply medication and treatments. They have learned, for example, that the sooner patients with respiratory problems are sent into intensive care treatment, the more chances they have of surviving.
Nationally, hospital admissions have kept increasing, slowly but steadily. According to the latest available official data, over 9% of normal beds and more than 17% of intensive care unit beds are devoted to treating COVID-19 patients at the national level, although the situation is far worse in the most affected areas.
Dr. César Carballo, an emergencies physician with the Ramón y Cajal Hospital in Madrid, says Spanish politicians have been slow in reacting to new outbreaks ever since anti-coronavirus restrictions were dropped as soon as the first wave was tamed.
“In Madrid there has been no real action until the data on hospital and ICU admissions told us how dire the situation was, but that should be the last-resort indicator that we should had been looking at,” Carballo said at an online discussion with colleagues on Tuesday.
“The alarm signals were there for everybody to see but nobody was looking," he said.
Parra reported from Madrid.